Hormone receptor expression in primary and recurrent high-grade serous ovarian cancer and its implications in early maintenance treatment

HIGHLIGHTS

  • who: Marcus Vetter and collaborators from the Gynecologic Center, University Basel, Spitalstrasse, Basel, Switzerland have published the article: Hormone Receptor Expression in Primary and Recurrent High-Grade Serous Ovarian Cancer and Its Implications in Early Maintenance Treatment, in the Journal: (JOURNAL) of 26/01/2020
  • what: The authors aimed to determine the role of estrogen and progesterone receptor expression in primary and paired relapsed HGSOC. In this study primary and matched relapsed tumor samples were collected from 80 patients with International Federation of Gynecology and Obstetrics Stage II-IV HGSOC.
  • how: Categorical data . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?